Results 11 to 20 of about 626,304 (143)

Anticorpos contra o citoplasma de neutrófilos Antineutrophil cytoplasmic antibodies [PDF]

open access: yesJornal Brasileiro de Pneumologia, 2005
A descoberta do marcador sorológico denominado anticorpo anticitoplasma de neutrófilos revolucionou o diagnóstico e o seguimento das vasculites pulmonares, especialmente da granulomatose de Wegener. Seu padrão pode ser citoplasmático e perinuclear.
Ari Stiel Radu, Mauricio Levi
doaj   +2 more sources

Antineutrophil cytoplasmic antibodies

open access: yesReumatismo, 2011
Antineutrophil cytoplasmic antibodies (ANCA) are predominantly IgG autoantibodies directed against constituents of primary granules of neutrophils and monocytes’ lysosomes.
G.D. Sebastiani
doaj   +2 more sources

Antineutrophil cytoplasmic antibodies in patients treated with methimazole: a prospective Brazilian study

open access: yesBrazilian Journal of Otorhinolaryngology, 2019
Introduction: The side effects of antithyroid drugs are well known. Antineutrophil cytoplasmic antibody-associated vasculitis is a severe adverse reaction.
Gabriela Costa Andrade   +4 more
doaj   +2 more sources

Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: Increased prevalence of ASCA and pANCA [PDF]

open access: yes, 2004
Aims: An association between inflammatory bowel disease (IBD) and spondyloarthropathies (SpA) has repeatedly been reported. The aim of the present study was to investigate whether serologic markers of IBD, e. g.
Folwaczny, Christian   +15 more
core   +1 more source

Serum antibodies in first-degree relatives of patients with IBD: A marker of disease susceptibility? A follow-up pilot-study after 7 years [PDF]

open access: yes, 2005
Introduction: Various disease-specific serum antibodies were described in patients with inflammatory bowel disease and their yet healthy first-degree relatives.
Török, H.-P.   +9 more
core   +1 more source

Anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: Potential clinical value [PDF]

open access: yes, 2002
Anti-Saccharomyces cerevisiae antibodies (ASCA) have been described as specific markers in Crohn's disease and their healthy first-degree relatives. 171 patients with Crohn's disease, their 105 first-degree relatives, 145 patients with ulcerative colitis
Török, H.-P.   +5 more
core   +1 more source

Case Report of Atypical Course of MPO-ANCA Associated Vasculitis

open access: yesZdorovʹe Rebenka, 2014
The classic form of vasculitis associated with antineutrophil cytoplasmic antibodies is characterized by progressive severe course, multiple lesions of internal organs and a general treatment strategy.
O.R. Boiarchuk, S.I. Smiian
doaj   +1 more source

Utility of serological markers in inflammatory bowel diseases: Gadget or magic? [PDF]

open access: yes, 2007
The panel of serologic markers for inflammatory bowel diseases (IBD) is rapidly expanding. Although anti-Saccharomyces cerevisiae antibodies (ASCA) and atypical perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) remain the most widely ...
Papp, Mária   +3 more
core   +1 more source

Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis

open access: yesClinical Case Reports, 2022
The diagnosis of antineutrophil cytoplasmic autoantibody‐associated vasculitis in first‐episode strokes is particularly challenging, especially in patients lacking features of systemic vasculitis.
John Chuan Nguyen Tran   +3 more
doaj   +1 more source

Proteinase 3 (PR3)-Antineutrophil Cytoplasmic Antibody in a Patient with Minimal Change Disease: An Unusual Finding [PDF]

open access: yesRevista Portuguesa de Nefrologia e Hipertensão, 2022
Antineutrophil cytoplasmic antibodies (ANCA) are useful as markers for systemic vasculitis. PR3-ANCA antibodies have been also identified in association with chronic inflammatory and infectious conditions, other autoimmune diseases, malignancy, and ...
Joana Freitas   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy